Abbott announced U.S. Food and Drug Administration (FDA) approval of a new alternative surgical technique for Abbott's HeartMate 3 heart pump that will allow more advanced heart failure patients to avoid open heart surgery. The new, less invasive approach is designed to provide surgeons a choice in surgical method for patients receiving the HeartMate 3 Left Ventricular Assist Device (LVAD).
January 07, 2020
FDA Approves Less Invasive Surgical Approach for HeartMate 3 Heart Pump
January 7, 2020 — Abbott announced U.S. Food and Drug Administration (FDA) approval of a new alternative surgical…
Read More
Figure 1 from the new ASE ischemia cardiac ultrasound imaging guidelines, showing a side-by-side views of apical 4- and 2-chamber images, at rest and immediately post-exercise. In the four-chamber view, the left ventricle is shown on the left-hand side of the screen. With exercise, the echocardiogram shows the LV cavity dilates (right quadrants) and there are regional wall motion abnormalities in the LAD territory.
January 07, 2020
New Guidelines for Stress Echocardiography in Ischemic Heart Disease
January 7, 2020 — The  American Society of Echocardiography (ASE) has updated its guidelines for using echocardiography…
Read More
The U.S. Food and Drug Administration (FDA) has accepted a supplemental new drug application (sNDA) from AstraZeneca and granted priority review for dapagliflozin (Farxiga) to reduce the risk of cardiovascular (CV) death or the worsening of heart failure (HF) in adults with heart failure with reduced ejection fraction (HFrEF) with and without type 2 diabetes (T2D).
January 07, 2020
Dapagliflozin Granted FDA Priority Review for Heart Failure With Reduced Ejection Fraction
January 7, 2020 — The U.S. Food and Drug Administration (FDA) has accepted a supplemental new drug application (sNDA)…
Read More
The top two articles on DAIC from 2019 included the FDA approval of two transcatheter aortic valve replacement (TAVR) systems for all surgical risk categories, making TAVR available to all patients based on recommendations by the heart team. The second biggest story of 2019 was the release of new atrial fibrillation guidelines recommend novel oral anticoagulants (NOACs) over the previous standard of care warfarin.
January 03, 2020
The Most Popular Cardiology Topics in 2019
January 3, 2020 — Here are the top 25 cardiology articles on the Diagnostic and Interventional Cardiology (DAIC)…
Read More
People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes. In early December 2019, leaders of the European Association for Cardiothoracic Surgery (EACTS) withdrew their support for European practice guidelines that endorse the use of coronary stents in many patients with left main coronary artery disease.
Dave Fornell, Editor
January 02, 2020
EXCEL Trial Authors Say European Surgery Society Claims of Bad Science Are Groundless
January 2, 2020 — In early December 2019, leaders of the European Association for Cardiothoracic Surgery (EACTS)…
Read More
This photo is from a MitraClip procedure during the University of Colorado visit last December.
Dave Fornell, Editor
December 30, 2019
Top 25 Cardiology Videos on DAIC in 2019
Here are the top performing 25 videos posted to the DAIC website in the past year, based on Google Analytics. These the…
Read More
December 30, 2019
Merit Medical Announces its EVOlution in Radial Hemostasis in Europe
December 30, 2019 — Merit Medical Systems Inc., a leading manufacturer of proprietary devices used primarily in…
Read More
ElectroSonix
December 30, 2019
ElectroSonix Licenses University of Arizona Patents for Acoustoelectric Imaging
December 30, 2019 — Acoustoelectric cardiac imaging, a new, noninvasive cardiac imaging technology developed at the…
Read More
Christie Ballantyne
December 30, 2019
Study Finds Drug Therapy for High Triglycerides to Have a Sustained Effect Using Low Dosages
December 30, 2019 — A drug therapy targeting the production of a protein produced by the liver has led to sustained and…
Read More
Cath Lab Philips Azurion angiography PCI
December 30, 2019
Study: Patients Overestimate Benefits of PCI
December 30, 2019 — Most patients do not understand or recall information given to them before heart procedures. For…
Read More
eko chest shot
December 30, 2019
Eko Announces Redesigned CORE Product Line
December 30, 2019 — Eko, a digital health company with an AI-powered cardiac screening platform, announced the second…
Read More
The U.S. Food and Drug Administration (FDA) has approved two applications for the first generics of the anticoagulant Eliquis (apixaban).
December 27, 2019
FDA Clears First Generics for Eliquis
December 27, 2019 — The U.S. Food and Drug Administration (FDA) has approved two applications for the first generics of…
Read More
The Wyss Translational Center in Zurich, Switzerland has developed the LifeMatrix platform to engineer tissues that can be implanted in patients and will grow with them. This technology is being developed for heart valves in younger patients to eliminate the need for repeat surgeries to implant larger prosthetic heart valves as the patient grows.
December 26, 2019
Tissue Engineering Will Disrupt Cardiovascular Implant Market
While transcatheter heart valve replacement and repair devices are growing in popularity due to their delivery and…
Read More
Peter Weiss, M.D., explains a Stereotaxis robotically navigated cardiac ablation procedure at Banner University Medicine Heart Institute.
J. Peter Weiss, M.D., MSc
December 23, 2019
Time to Take Another Look at Robotics in Electrophysiology
Robotic technology, which helps carry out repetitive tasks efficiently and precisely, has been gaining ground in…
Read More
Top Cardiology New in 2019 From the European Society of Cardioloigy (ESC)
December 23, 2019
Top Cardiology News in 2019 From the European Society of Cardiology (ESC)
Environmental and lifestyle issues were popular this year, with pick up from both European Society of Cardiology (ESC)…
Read More
Developed by Eko, a digital health company applying artificial intelligence (AI) in heart disease, the algorithm analyzes 15 seconds of ECG data collected from the Eko Duo digital stethoscope. The data can be collected during a physical exam and helps identify reduced left ventricular ejection fraction (LVEF), a measure commonly used to diagnose patients with heart failure.
December 19, 2019
FDA Grants Breakthrough Designation to Ekos ECG-based Low Ejection Fraction Screening Algorithm
December 19, 2019 — The U.S. Food and Drug Administration (FDA) has granted breakthrough status for a novel ECG-based…
Read More
heart disease image
December 18, 2019
The Cardiovascular Disease Technology Market Will Exceed $40 Billion by 2030
December 18, 2019 — In their latest report, “Cardiovascular Disease 2020-2030: Trends, Technologies & Outlook”…
Read More
Append Medical, developer of a novel left atrial appendage (LAA) closure device to minimize stroke risk in atrial fibrillation (AF) patients, announced that it has been selected from among hundreds of startups as a finalist for the ICI Innovation Award Competition. It uses a transcatheter lasso system so no implant is left behind and eliminates the possibility of embolization.
December 18, 2019
First-Of-Its-Kind, No-Implant LAA Occluder Noted for Innovation at 2019 ICI Meeting
December 18, 2019 — Append Medical, developer of a novel left atrial appendage (LAA) closure device to minimize stroke…
Read More
Revivant TC
December 18, 2019
BioVentrix Announces Publication of Positive One-Year Outcomes for Revivent TC System
December 18, 2019 — BioVentrix, Inc., developer of the first less invasive system for left ventricular remodeling,…
Read More
December 18, 2019
Cook Medical Recalls CrossCath Support Catheters Due to Marker Bands Dislodging
December 18, 2019 — Cook Medical initiated a recall of its CrossCath Support Catheters in November, which the U.S. Food…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now